|
May 6
|
5 Biotech Stocks Worth Adding to Your Portfolio in 2024
|
|
May 3
|
Agios (AGIO) Q1 Earnings Surpass, Sales Miss Estimates
|
|
May 3
|
Blueprint (BPMC) Q1 Earnings and Revenues Beat, Stock Rises
|
|
May 2
|
Zoetis (ZTS) Q1 Earnings and Revenues Surpass Estimates
|
|
May 2
|
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
|
|
May 2
|
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
|
|
May 2
|
Novo Nordisk (NVO) Q1 Earnings Beat, GLP-1 Drugs Boost Sales
|
|
Apr 26
|
Sage Therapeutics (SAGE) Q1 Earnings Miss, Sales Beat Estimates
|
|
Apr 23
|
Ligand to Report First Quarter 2024 Financial Results on May 7, 2024
|
|
Apr 17
|
Wall Street Analysts Predict a 45.56% Upside in Ligand (LGND): Here's What You Should Know
|
|
Apr 16
|
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
|
|
Apr 16
|
Marinus (MRNS) Down 83% on Lead Drug Falling Short in Seizure Study
|
|
Apr 15
|
Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why
|
|
Apr 9
|
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
|
|
Apr 9
|
Corcept (CORT) Completes Enrollment in Ovarian Cancer Study
|
|
Apr 9
|
Palatin (PTN) Up 15% on Results From Dry Eye Disease Study
|
|
Apr 9
|
Can Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Performance Keep Up Given Its Mixed Bag Of Fundamentals?
|
|
Apr 8
|
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why
|
|
Apr 8
|
Ligand Pharmaceuticals Announces New Topiramate Injection Data Presented at 9th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures Conference
|
|
Apr 8
|
MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why
|